Conversion of abiraterone to D4A drives antitumor activity in prostate cancer

Conversion of abiraterone to D4A drives antitumor activity in prostate cancer

Prostate cancer resistance to castration occurs because tumors acquire the metabolic capability of converting precursor steroids to 5α-dihydrotestosterone (DHT), promoting signaling by the androgen receptor (AR) and the development of castration-resistant prostate cancer (CRPC)1–3. Essential for res...

Full description

Bibliographic Details
Main Authors: Li, Zhenfei, Bishop, Andrew, Alyamani, Mohammad, Garcia, Jorge A., Dreicer, Robert, Bunch, Dustin, Liu, Jiayan, Upadhyay, Sunil K., Auchus, Richard J., Sharifi, Nima
Format: Online
Language:English
Published: 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506215/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506215/

Similar Items